Vycor Medical Inc
VYCO· OTC
Filed Aug 14, 2015 · 10-Q · 45 days after period end · 0001354488-15-003895
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Revenue | $286.02K | $298.54K | $234.95K | $265.39K |
| Net Income | -$420.27K | -$1.28M | -$647.83K | -$797.73K |
| EPS Diluted | -$0.04 | -$0.12 | -$0.10 | -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
ended Jun 30, 2015 · filed Aug 14, 2015 · 45 d after period end